Home › Pemphigus › Pennsylvania › Philadelphia
Pemphigus clinical trials in Philadelphia, PA
3 studies for Pemphigus are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
Autoimmune Blistering Diseases Study
RecruitingObservational study
- Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Department of Dermatology, Philadelphia
About Pemphigus
Pemphigus and bullous pemphigoid are an autoimmune disorder, affects cells in your skin and mouth. Learn about symptoms, diagnosis, and treatment.
More about Pemphigus on MedlinePlus
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.